![](https://bloximages.newyork1.vip.townnews.com/wfmz.com/content/tncms/custom/image/b9818ac0-ee9a-11e9-8e9f-a3b831b71481.jpg?resize=600%2C338)
Lykos Therapeutics Announces Reorganization to Address FDA's Recent Decision on Midomafetamine Capsules for PTSD
- Pharmaceutical industry veteran and former Janssen executive Dr. David Hough appointed senior medical advisor to oversee clinical and regulatory - Lykos to significantly reduce workforce, streamlining organization around clinical development and …